Literature DB >> 22798665

NK and CD4+ T cell cooperative immune responses correlate with control of disease in a macaque simian immunodeficiency virus infection model.

Diego A Vargas-Inchaustegui1, Peng Xiao, Iskra Tuero, L Jean Patterson, Marjorie Robert-Guroff.   

Abstract

Control of infectious disease may be accomplished by successful vaccination or by complex immunologic and genetic factors favoring Ag-specific multicellular immune responses. Using a rhesus macaque model, we evaluated Ag-specific T cell-dependent NK cell immune responses in SIV-infected macaques, designated "controlling" or "noncontrolling" based on long-term chronic viremia levels, to determine whether NK cell effector functions contribute to control of SIV infection. We observed that Gag stimulation of macaque PBMCs induced subset-specific NK cell responses in SIV-controlling but not SIV-noncontrolling animals, as well as that circulatory NK cell responses were dependent on Ag-specific IL-2 production by CD4(+) central memory T cells. NK cell activation was blocked by anti-IL-2-neutralizing Ab and by CD4(+) T cell depletion, which abrogated the Gag-specific responses. Among tissue-resident cells, splenic and circulatory NK cells displayed similar activation profiles, whereas liver and mucosal NK cells displayed a decreased activation profile, similar in SIV-controlling and -noncontrolling macaques. Lack of T cell-dependent NK cell function was rescued in SIV-noncontrolling macaques through drug-mediated control of viremia. Our results indicate that control of disease progression in SIV-controlling macaques is associated with cooperation between Ag-specific CD4(+) T cells and NK cell effector function, which highlight the importance of such cell-to-cell cooperativity in adaptive immunity and suggest that this interaction should be further investigated in HIV vaccine development and other prophylactic vaccine approaches.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22798665      PMCID: PMC3411935          DOI: 10.4049/jimmunol.1201026

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  47 in total

1.  CD56bright natural killer cells are present in human lymph nodes and are activated by T cell-derived IL-2: a potential new link between adaptive and innate immunity.

Authors:  Todd A Fehniger; Megan A Cooper; Gerard J Nuovo; Marina Cella; Fabio Facchetti; Marco Colonna; Michael A Caligiuri
Journal:  Blood       Date:  2002-12-12       Impact factor: 22.113

2.  T cell-dependent production of IFN-gamma by NK cells in response to influenza A virus.

Authors:  Xiao-Song He; Monia Draghi; Kutubuddin Mahmood; Tyson H Holmes; George W Kemble; Cornelia L Dekker; Ann M Arvin; Peter Parham; Harry B Greenberg
Journal:  J Clin Invest       Date:  2004-12       Impact factor: 14.808

3.  HIV-1-infected children on HAART: immunologic features of three different levels of viral suppression.

Authors:  Carlos Alberto Zaccarelli-Filho; Erika Ono; Daisy Maria Machado; Milena Brunialti; Regina Célia de Menezes Succi; Reinaldo Salomão; Esper Georges Kallás; Maria Isabel de Moraes-Pinto
Journal:  Cytometry B Clin Cytom       Date:  2007-01-15       Impact factor: 3.058

4.  Distinctive lack of CD48 expression in subsets of human dendritic cells tunes NK cell activation.

Authors:  Barbara Morandi; Roberta Costa; Michela Falco; Silvia Parolini; Andrea De Maria; Giovanni Ratto; Maria Cristina Mingari; Giovanni Melioli; Alessandro Moretta; Guido Ferlazzo
Journal:  J Immunol       Date:  2005-09-15       Impact factor: 5.422

Review 5.  The biology of human natural killer-cell subsets.

Authors:  M A Cooper; T A Fehniger; M A Caligiuri
Journal:  Trends Immunol       Date:  2001-11       Impact factor: 16.687

6.  CD16+ NK cells decrease in all stages of HIV infection through a selective depletion of the CD16+CD8+CD3- subset.

Authors:  I Mansour; C Doinel; P Rouger
Journal:  AIDS Res Hum Retroviruses       Date:  1990-12       Impact factor: 2.205

7.  Evidence of NK cell dysfunction in SIV-infected rhesus monkeys: impairment of cytokine secretion and NKG2C/C2 expression.

Authors:  Michelle L LaBonte; Paul F McKay; Norman L Letvin
Journal:  Eur J Immunol       Date:  2006-09       Impact factor: 5.532

Review 8.  Dendritic cells and natural killer cells in the pathogenesis of HIV infection.

Authors:  Claudio Fortis; Guido Poli
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

9.  Characterization of CD56-/CD16+ natural killer (NK) cells: a highly dysfunctional NK subset expanded in HIV-infected viremic individuals.

Authors:  Domenico Mavilio; Gabriella Lombardo; Janet Benjamin; Diana Kim; Dean Follman; Emanuela Marcenaro; M Angeline O'Shea; Audrey Kinter; Colin Kovacs; Alessandro Moretta; Anthony S Fauci
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-07       Impact factor: 11.205

Review 10.  Natural killer cells as an initial defense against pathogens.

Authors:  Melissa B Lodoen; Lewis L Lanier
Journal:  Curr Opin Immunol       Date:  2006-06-12       Impact factor: 7.486

View more
  18 in total

Review 1.  Innate immunity against HIV-1 infection.

Authors:  Marcus Altfeld; Michael Gale
Journal:  Nat Immunol       Date:  2015-06       Impact factor: 25.606

2.  Two-Year Follow-Up of Macaques Developing Intermittent Control of the Human Immunodeficiency Virus Homolog Simian Immunodeficiency Virus SIVmac251 in the Chronic Phase of Infection.

Authors:  Iart Luca Shytaj; Gabrielle Nickel; Eric Arts; Nicholas Farrell; Mauro Biffoni; Ranajit Pal; Hye Kyung Chung; Celia LaBranche; David Montefiori; Diego Vargas-Inchaustegui; Marjorie Robert-Guroff; Mark G Lewis; Jonah B Sacha; Anna Teresa Palamara; Andrea Savarino
Journal:  J Virol       Date:  2015-05-13       Impact factor: 5.103

3.  Therapeutic envelope vaccination in combination with antiretroviral therapy temporarily rescues SIV-specific CD4⁺ T-cell-dependent natural killer cell effector responses in chronically infected rhesus macaques.

Authors:  Diego A Vargas-Inchaustegui; Peng Xiao; Thorsten Demberg; Ranajit Pal; Marjorie Robert-Guroff
Journal:  Immunology       Date:  2015-06       Impact factor: 7.397

4.  Phenotypic and Functional Characterization of Circulatory, Splenic, and Hepatic NK Cells in Simian Immunodeficiency Virus-Controlling Macaques.

Authors:  Diego A Vargas-Inchaustegui; Sabrina Helmold Hait; Hye Kyung Chung; Jigna Narola; Tanya Hoang; Marjorie Robert-Guroff
Journal:  J Immunol       Date:  2017-09-25       Impact factor: 5.422

Review 5.  NK cells in host responses to viral infections.

Authors:  Viola C Lam; Lewis L Lanier
Journal:  Curr Opin Immunol       Date:  2016-12-13       Impact factor: 7.486

Review 6.  NK cells and their ability to modulate T cells during virus infections.

Authors:  Kevin D Cook; Stephen N Waggoner; Jason K Whitmire
Journal:  Crit Rev Immunol       Date:  2014       Impact factor: 2.214

7.  Fc receptor-mediated immune responses: new tools but increased complexity in HIV prevention.

Authors:  Diego A Vargas-Inchaustegui; Marjorie Robert-Guroff
Journal:  Curr HIV Res       Date:  2013-07       Impact factor: 1.581

Review 8.  Mucosal immunology of HIV infection.

Authors:  Huanbin Xu; Xiaolei Wang; Ronald S Veazey
Journal:  Immunol Rev       Date:  2013-07       Impact factor: 12.988

9.  Innate Immune Activity Correlates with CD4 T Cell-Associated HIV-1 DNA Decline during Latency-Reversing Treatment with Panobinostat.

Authors:  Rikke Olesen; Selena Vigano; Thomas A Rasmussen; Ole S Søgaard; Zhengyu Ouyang; Maria Buzon; Arman Bashirova; Mary Carrington; Sarah Palmer; Christel R Brinkmann; Xu G Yu; Lars Østergaard; Martin Tolstrup; Mathias Lichterfeld
Journal:  J Virol       Date:  2015-07-29       Impact factor: 5.103

10.  Diminished viral control during simian immunodeficiency virus infection is associated with aberrant PD-1hi CD4 T cell enrichment in the lymphoid follicles of the rectal mucosa.

Authors:  Geetha H Mylvaganam; Vijayakumar Velu; Jung-Joo Hong; Shanmugalakshmi Sadagopal; Suefen Kwa; Rahul Basu; Benton Lawson; Francois Villinger; Rama Rao Amara
Journal:  J Immunol       Date:  2014-09-22       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.